Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pegylated recombinant arginine deiminase

EU orphan designation number: EU/3/14/1409   
Active ingredient: Pegylated recombinant arginine deiminase
Indication: Treatment of malignant mesothelioma
Sponsor: Designerx Europe Limited c/o Olswang LLP
Cannon Place, 78 Cannon Street, London EC4N 6AF, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/01/2015 Orphan designation EMA/OD/076/14 (2015)173 of 15/01/2015
12/07/2017 Change of name and/or address of sponsor